Skip to main content

Advertisement

SpringerLink
Log in

Primäre Immundefekte

Ergebnisse einer europäischen Public-Health-Konsensuskonferenz

Primary immunodeficiencies. Results of an European public health consensus conference

  • Leitthema: Seltene Krankheiten, Teil 1
  • Published:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Aims and scope

Zusammenfassung

Primäre Immundefekterkrankungen (PID) stellen für die Betroffenen, aber auch für die Gesellschaft und das Gesundheitssystem eine erhebliche Belastung dar. Über 150 genetisch gut charakterisierte angeborene Immundefekte sind heute bekannt. Auch wenn in Deutschland von mehr als 100.000 betroffenen Menschen auszugehen ist, sind derzeit nur etwa 1400 Patienten diagnostiziert und in Behandlung. Es besteht also ganz offenbar ein großes Defizit in Bezug auf Aufklärung, Diagnostik und adäquate Therapie. Das Thema wurde ausführlich auf einer EU-geförderten Konsensuskonferenz im Juni 2006 am Paul-Ehrlich-Institut in Langen behandelt. Einige der wichtigsten Ergebnisse sind hier zusammengefasst.

Abstract

Primary immunodeficiencies (PID) re present for the patients but also for society and our health care system a significant burden. More than 500 genetically well characterized inborn immunodeficiencies have been described to date. In Germany we expect 100,000 to be affected by this disease, but only about 1,400 patients have been diagnosed and are under treatment. There is a tremendous lack of information, diagnostics and adequate therapy. The topic was discussed extensively at an EU-funded consensus conference in June 2006 at the Paul Ehrlich Institute in Langen. The most important results are summarized in this article.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Notarangelo L, Casanova JL, Conley ME, et al. (2006) Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest 2005. J Allergy Clin Immunol 117:883–896

    Article  PubMed  Google Scholar 

  2. Quinti I, Pierdominici M, Marziali M, et al. (2002) European surveillance of immunoglobulin safety – results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries. Clin Immunol 104:231–236

    Article  PubMed  CAS  Google Scholar 

  3. Schmidt RE (1998) Defekte des Immunsystems (I) – Klinik, diagnostisches Vorgehen und Therapie. Allergologie 4:166

    Google Scholar 

  4. Schmidt RE (1998) Defekte des Immunsystems (II) – Klinik, diagnostisches Vorgehen und Therapie. Allergologie 6:279

    Google Scholar 

  5. Chapel HM (1994) Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies. MJ 308:581–585

    CAS  Google Scholar 

  6. Cunningham-Rundles C, Liebermann P, Hellman G, Chaganti RS (1991) Non-Hodgkin lymphoma in common variable immunodeficiency. Am J Hematol 37:69–74

    Article  PubMed  CAS  Google Scholar 

  7. Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48

    Article  PubMed  CAS  Google Scholar 

  8. Grimbacher B, Hutloff A, Schlesier M, et al. (2003) Homozygous loss of ICOS is associated with adultonset common variable immunodeficiency. Nat Immunol 4:261–268

    Article  PubMed  CAS  Google Scholar 

  9. Van Zelm MC, Reisli I, van der Burg M, et al. (2006) An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 354:1901–1912

    Article  PubMed  CAS  Google Scholar 

  10. Salzer U, Chapel HM, Webster ADB, et al. (2005) Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genetics 37:820–828

    Article  CAS  Google Scholar 

  11. Seymour B, Miles J, Haeney M (2005) Primary antibody deficiency and diagnostic delay. J Clin Pathol 58:546–547

    Article  PubMed  CAS  Google Scholar 

  12. Wahn V, Belohradsky BH, Borte M, et al. (2007) Früherkennung von Patienten mit primären Immundefekten, Behandlung von Patienten mit Antikörpermangel. Internist Prax 47:247–254

    Google Scholar 

  13. http://www.eupidconference.com

  14. Rose ME, Lang DM (2006) Evaluating and managing hypogammaglobulinemia. Cleve Clin J Med 73:133–144

    Article  PubMed  Google Scholar 

  15. Wood P, Stanworth S, Burton J, et al. (2007) Chapel H on behalf of the UK Primary Immunodeficiency Network. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol (in press)

Download references

Author information

Authors and Affiliations

  1. Medizinische Hochschule, Hannover, BRD

    Reinhold E. Schmidt

  2. Klinische Immunologie und Rheumatologie, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover, BRD

    Reinhold E. Schmidt

Authors
  1. Reinhold E. Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reinhold E. Schmidt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidt, R.E. Primäre Immundefekte. Bundesgesundheitsbl. 50, 1502–1506 (2007). https://doi.org/10.1007/s00103-007-0384-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00103-007-0384-6

Schlüsselwörter

Keywords

Search

Navigation